BerGenBio ASA announces the appointment of Anders Tullgren to succeed Sveinung Hole as Chairman of the Board of Directors, effective today. Sveinung Hole has been Chairman of the Board since March 2019 and will continue to serve as a Board Member. He spent over 20 years at Bristol Myers Squibb, most recently as President, Intercontinental Region at the firm, with responsibility across 30 countries, 5,000 employees and a turnover of over USD 2.7 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.28 NOK | -1.11% | +13.15% | -48.63% |
05-29 | BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-29 | Transcript : BerGenBio ASA, Q1 2024 Earnings Call, May 29, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.63% | 53.86M | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- BGBIO Stock
- News BerGenBio ASA
- BerGenBio ASA Announces Change of Chairman of Board